1. Naber CK, Hammer H, Kinzig-Schippers M, Sörgel F, Naber KG. Urinary excretion and bacterial activity of levofloxacin versus ciprofloxacin in healthy volunteers after a single oral dose of 500mg. 9th International Congress on Infectious Diseases, Buenos Aires, Argentina, 10-13 April 2000. Poster # 10920.
2. Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK . Chronic Prostatitis Workshop, Bethesda, MD, 7-8 December, 1995.
3. Bulitta J, Kinzig-Schippers M, Naber CK, Naber KG, Sauber C, Kleinschnitz M, et al. Limitations in the use of drug cocktails (DC) to compare pharmacokinetics (PK) of drugs: ciprofloxacin (CIP) vs. levofloxacin (LEV). 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada, Sept. 17-20, 2000, Poster #506.
4. Kahn JB, Newton PA, Wu S, Bossumini L, Wiesinger BA, Tennenberg AM. The changing etiology of chronic bacterial prostatitis (CBP). 42nd ICAAC, San Diego, California, USA, September 27-30, 2002. Abstract L-1801.